Case 474 · ICHD-3 7.3.3
7.3.3 Headache attributed to other non-infectious inflammatory intracranial disease
- Origin
- Synthetic
- Language
- English — also available in German
- Contributed by
- Imported case — HeadAI synthetic vignettes (de Andrade JBC, da Silva Costa TB, Vasconcelos JL, Lopes TLM, Balsells MD, Cristofolini VL, Querobin SO, Filho FMR. Validation of an AI-based platform for structured diagnosis of headache disorders using ICHD-3 criteria. BMC Neurology 25, 489 (2025). doi:10.1186/s12883-025-04473-1. Dataset: Andrade J. Head.AI Platform. Mendeley Data, V2 (2025). doi:10.17632/4fms6cw2s5.2)
Anamnesis
Identification: Sex/Age: Female, 28 years.
History: Systemic lupus erythematosus (SLE) under treatment with prednisone and hydroxychloroquine for 3 years.
Current Medications: Prednisone 10 mg/day, hydroxychloroquine 400 mg/day.
History of Present Illness (HPI): Main symptom: Diffuse headache for 1 week, with gradual onset.
Pain characteristics:
Location: Bifrontal and occipital.
Character: Continuous pressure.
Intensity: 7/10.
Aggravation: Worsens with eye movements and upon waking.
Associated symptoms:
Blurred vision.
Nausea without vomiting.
Intense fatigue.
Relevant factors: History of SLE with recent inflammatory activity (arthralgias and skin rash).
Physical/Neurological Examination: General: Patient conscious, but with marked asthenia.
Neurological:
Cranial nerves: Right diplopia (partial paralysis of the VI cranial nerve).
Fundoscopy: Mild bilateral papilledema.
Meningeal signs: Negative.
Muscle strength and sensation: Normal.
Complementary Exams: Magnetic Resonance Imaging of the Brain:
Findings: Leptomeningeal thickening with post-contrast enhancement in frontoparietal regions.
Cerebrospinal Fluid (CSF):
Lymphocytic leukocytosis (25 cells/mm³).
Elevated proteins (80 mg/dL).
Normal glucose levels.
Cultures negative for bacteria, viruses, and fungi.
Laboratory:
Anti-double-stranded DNA positive (↑↑).
ESR and CRP elevated.
Report this case — e.g. suspected re-identification risk.